|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Assets: | |||
| Current Assets | |||
| Cash | |||
| Prepaid expenses | |||
| Prepaid insurance | |||
| Total Current Assets | |||
| Deferred offering costs | |||
| Prepaid insurance – long term | |||
| Investments held in Trust Account | |||
| Total Assets | |||
| Liabilities and Shareholder’s Deficit: | |||
| Accrued expenses | |||
| Current Liabilities | |||
| Accounts payable and accrued expenses | |||
| Accrued offering costs | |||
| Promissory note - related party | |||
| Promissory note – related party | |||
| Total Current Liabilities | |||
| Deferred legal fee | |||
| Deferred underwriting fee payable | |||
| Total Liabilities | |||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 and no shares at redemption value of $10.12 and $0 per share at June 30, 2026 and December 31, 2025, respectively | |||
| Shareholders’ Deficit: | |||
| Ordinary shares, value | |||
| Class A Ordinary Shares | |||
| Class B Ordinary Shares | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
